Open Access. Powered by Scholars. Published by Universities.®
- Institution
-
- University of Kentucky (52)
- Chapman University (33)
- St. John Fisher University (25)
- Butler University (12)
- Campbell University (10)
-
- Touro College and University System (10)
- Harding University (9)
- Southwestern Oklahoma State University (9)
- East Tennessee State University (7)
- Marshall University (6)
- Nova Southeastern University (6)
- Technological University Dublin (6)
- Thomas Jefferson University (6)
- University of Rhode Island (6)
- Virginia Commonwealth University (6)
- Western University (6)
- Cedarville University (5)
- University of Nebraska - Lincoln (5)
- Wayne State University (5)
- Baptist Health South Florida (4)
- University of Mississippi (4)
- Ohio Northern University (3)
- Old Dominion University (3)
- University of Connecticut (3)
- University of Montana (3)
- University of Nebraska Medical Center (3)
- West Virginia University (3)
- Antioch University (2)
- Lehigh Valley Health Network (2)
- Parkland College (2)
- Keyword
-
- Pharmacy (20)
- Humans (13)
- Animals (9)
- Rural (8)
- Rural Rocks (8)
-
- Fsc2016 (7)
- Male (7)
- Pharmacists (7)
- Pharmacy Practice (7)
- Diabetes (5)
- Female (5)
- Fsc2017 (5)
- Health care (5)
- Library Impact Statement, Faculty Senate, Pharmacy, Collection Development (5)
- Models, Molecular (5)
- Cancer (4)
- Library science (4)
- Mice (4)
- Obesity (4)
- Venous thromboembolism (4)
- Blood (3)
- Breast cancer (3)
- Butyrylcholinesterase (3)
- Cedarville (3)
- Community pharmacy (3)
- Drug delivery (3)
- FDA (3)
- Hydroxyapatite (3)
- Molecular Conformation (3)
- Pharmacokinetics (3)
- Publication
-
- Pharmacy Faculty Articles and Research (31)
- Pharmacy Faculty/Staff Publications (23)
- Pharmaceutical Sciences Faculty Publications (15)
- Scholarship and Professional Work – COPHS (12)
- College of Pharmacy Faculty Research and Publications (9)
-
- Pharmaceutical Sciences (9)
- Pharmaceutical Sciences Faculty Patents (9)
- RURAL ROCKS (8)
- ETSU Faculty Works (7)
- Molecular Modeling and Biopharmaceutical Center Faculty Publications (6)
- Pharmacy Practice and Science Faculty Publications (6)
- Physiology and Pharmacology Publications (6)
- Library Impact Statements (5)
- All Publications (4)
- Department of Pharmacy Practice (4)
- Faculty Publications & Research of the TUC College of Pharmacy (4)
- Food and Drug Administration Papers (4)
- Medicinal Chemistry Publications (4)
- Touro College of Pharmacy (New York) Publications and Research (4)
- Articles (3)
- College of Pharmacy Faculty Papers (3)
- Doctoral (3)
- Faculty & Staff Scholarship (3)
- Health Professions Divisions Course Catalogs and Course Descriptions (3)
- Honors Scholar Theses (3)
- Internal Medicine Faculty Publications (3)
- Pharmacy Faculty Scholarship (3)
- 2016 White Coat Ceremony Documents and Video (2)
- Antioch University Full-Text Dissertations & Theses (2)
- Biomedical and Pharmaceutical Sciences Faculty Publications (2)
Articles 1 - 30 of 275
Full-Text Articles in Medicine and Health Sciences
Research News. Publications, 2016. Volume 2, University Of Mississippi. School Of Pharmacy, Soumyajit Majumdar
Research News. Publications, 2016. Volume 2, University Of Mississippi. School Of Pharmacy, Soumyajit Majumdar
Publications (2015-)
Publications that appeared during the period July 1 through December 31, 2016
Research News. Grants, 2016. Volume 2, University Of Mississippi. School Of Pharmacy, Soumyajit Majumdar
Research News. Grants, 2016. Volume 2, University Of Mississippi. School Of Pharmacy, Soumyajit Majumdar
Grants (2015-)
Grants and contracts awarded during July-December 2016
Assessment Of Achieved Systolic Blood Pressure In Newly Treated Hypertensive Patients Aged 60-79 Years Before And After Eighth Joint National Committee Recommendations, Michael S. Kelly, Joseph J. Saseen, Joel C. Marrs
Assessment Of Achieved Systolic Blood Pressure In Newly Treated Hypertensive Patients Aged 60-79 Years Before And After Eighth Joint National Committee Recommendations, Michael S. Kelly, Joseph J. Saseen, Joel C. Marrs
Pharmacy Faculty Articles and Research
Objective:
To determine whether patients who were newly prescribed antihypertensive therapy after the Eighth Joint National Committee (JNC 8) update were treated to a relaxed systolic blood pressure (SBP) goal compared with patients treated before the update.
Methods:
A retrospective cohort study approved by the Colorado Multiple Institutional Review Board. Patients aged 60–79 years, without diabetes or chronic kidney disease (CKD), newly treated for hypertension at a University of Colorado primary care clinics were included. The mean first-achieved and last-stable SBPs of patients newly prescribed antihypertensive medications from 1 January 2012 to 31 December 31 2013 (before cohort) were compared …
Antitumor Activity Of 2,9-Di-Sec-Butyl-1,10-Phenanthroline, Dongsheng Wang, Shifang Peng, Arm R. Amin, Mohammad Aminur Rahman, Sreenivas Nannapaneni, Yuan Liu, Dong M. Shin, Nabil F. Saba, Jack F. Eichler, Zhuo G. Chen
Antitumor Activity Of 2,9-Di-Sec-Butyl-1,10-Phenanthroline, Dongsheng Wang, Shifang Peng, Arm R. Amin, Mohammad Aminur Rahman, Sreenivas Nannapaneni, Yuan Liu, Dong M. Shin, Nabil F. Saba, Jack F. Eichler, Zhuo G. Chen
Pharmaceutical Science and Research
The anti-tumor effect of a chelating phen-based ligand 2,9-di-sec-butyl-1,10-phenanthroline (dsBPT) and its combination with cisplatin were examined in both lung and head and neck cancer cell lines and xenograft animal models in this study. The effects of this agent on cell cycle and apoptosis were investigated. Protein markers relevant to these mechanisms were also assessed. We found that the inhibitory effect of dsBPT on lung and head and neck cancer cell growth (IC50 ranged between 0.1–0.2 μM) was 10 times greater than that on normal epithelial cells. dsBPT alone induced autophagy, G1 cell cycle arrest, and apoptosis. Our in vivo …
Impact Of Time-Varying Treatment Exposures On The Risk Of Venous Thromboembolism In Multiple Myeloma, Joshua D. Brown, Val R. Adams, Daniela C. Moga
Impact Of Time-Varying Treatment Exposures On The Risk Of Venous Thromboembolism In Multiple Myeloma, Joshua D. Brown, Val R. Adams, Daniela C. Moga
Pharmacy Practice and Science Faculty Publications
Multiple myeloma (MM) has one of the highest risks of venous thromboembolism (VTE) of all cancers due to pathologic changes and treatment-related exposures. This study assessed the one-year incidence of VTE in newly diagnosed MM and to determine the baseline and time-varying treatment-related factors associated with VTE risk in a U.S.-based cohort. MM patients were identified and age, gender, and baseline comorbidities were determined. Treatment-related exposures included thalidomide derivatives (IMIDs), proteasome inhibitors, cytotoxic chemotherapy, steroids, erythropoietin-stimulating agents (ESAs), stem cell transplants (SCT), hospitalizations, infection, and central venous catheters (CVC). Multiple statistical models were used including a baseline competing risks model, …
Current And Evolving Approaches For Improving The Oral Permeability Of Bcs Class Iii Or Analogous Molecules, Vivek S. Dave, Deepak Gupta, Monica Yu, Phong Nguyen, Sheeba Varghese Gupta
Current And Evolving Approaches For Improving The Oral Permeability Of Bcs Class Iii Or Analogous Molecules, Vivek S. Dave, Deepak Gupta, Monica Yu, Phong Nguyen, Sheeba Varghese Gupta
Pharmacy Faculty/Staff Publications
The Biopharmaceutics Classification System (BCS) classifies pharmaceutical compounds based on their aqueous solubility and intestinal permeability. The BCS Class III compounds are hydrophilic molecules (high aqueous solubility) with low permeability across the biological membranes. While these compounds are pharmacologically effective, poor absorption due to low permeability becomes the rate-limiting step in achieving adequate bioavailability. Several approaches have been explored and utilized for improving the permeability profiles of these compounds. The approaches include traditional methods such as prodrugs, permeation enhancers, ion-pairing, etc., as well as relatively modern approaches such as nanoencapsulation and nanosizing. The most recent approaches include a combination/hybridization of …
Advances And Perspectives In Genetics Of Congenital Thyroid Disorders Associated With Thyroglobulin Gene Mutations, Héctor M. Targovnik, Cintia E. Citterio, Sofi Siffo, Carina M. Rivolta
Advances And Perspectives In Genetics Of Congenital Thyroid Disorders Associated With Thyroglobulin Gene Mutations, Héctor M. Targovnik, Cintia E. Citterio, Sofi Siffo, Carina M. Rivolta
Pharmacy Faculty Articles and Research
Dyshormonogenesis due to thyroglobulin (TG) gene mutations is a rare cause of congenital hypothyroidism with an estimated incidence of approximately 1 in 100,000 newborns. The TG gene is organized in 48 exons, spanning over 270 kb on human chromosome 8q24. The human TG mRNA is 8.5 Kb long and the preprotein monomer is composed of a 19 amino acids signal peptide followed by a 2749 residues polypeptide. Until now, one hundred seventeen deleterious mutations in the human TG gene have been identified and characterized, originating structural changes in the protein that alter the normal protein folding, assembly and …
Comparison Of Outcomes Following A Switch From A Brand To An Authorized Vs. Independent Generic Drug, Richard Hansen, Jingjing Qian, Richard L. Berg, James G. Linneman, Enrique Seoane-Vazquez, Sarah Dutcher, Saeid Raofi, C. David Page, Peggy L. Peissig
Comparison Of Outcomes Following A Switch From A Brand To An Authorized Vs. Independent Generic Drug, Richard Hansen, Jingjing Qian, Richard L. Berg, James G. Linneman, Enrique Seoane-Vazquez, Sarah Dutcher, Saeid Raofi, C. David Page, Peggy L. Peissig
Pharmacy Faculty Articles and Research
Authorized generics are identical in formulation to brand drugs, manufactured by the brand company but marketed as a generic. Generics, marketed by generic manufacturers, are required to demonstrate pharmaceutical and bioequivalence to the brand drug, but repetition of clinical trials is not required. This retrospective cohort study compared outcomes for generics and authorized generics, which serves as a generic vs. brand proxy that minimizes bias against generics. For the seven drugs studied between 1999-2014, 5,234 unique patients were on brand drug prior to generic entry and 4,900 (93.6%) switched to a generic. During the 12-months following the brand-to-generic switch, patients …
December 2016, Randy Curry, Cindy Brooks
December 2016, Randy Curry, Cindy Brooks
RURAL ROCKS
Rural Rocks, the Rural Health Network newsletter by the SWOSU College of Pharmacy
Molecular Mechanism: The Human Dopamine Transporter Histidine 547 Regulates Basal And Hiv-1 Tat Protein-Inhibited Dopamine Transport, Pamela M. Quizon, Wei-Lun Sun, Yaxia Yuan, Narasimha M. Midde, Chang-Guo Zhan, Jun Zhu
Molecular Mechanism: The Human Dopamine Transporter Histidine 547 Regulates Basal And Hiv-1 Tat Protein-Inhibited Dopamine Transport, Pamela M. Quizon, Wei-Lun Sun, Yaxia Yuan, Narasimha M. Midde, Chang-Guo Zhan, Jun Zhu
Molecular Modeling and Biopharmaceutical Center Faculty Publications
Abnormal dopaminergic transmission has been implicated as a risk determinant of HIV-1-associated neurocognitive disorders. HIV-1 Tat protein increases synaptic dopamine (DA) levels by directly inhibiting DA transporter (DAT) activity, ultimately leading to dopaminergic neuron damage. Through integrated computational modeling prediction and experimental validation, we identified that histidine547 on human DAT (hDAT) is critical for regulation of basal DA uptake and Tat-induced inhibition of DA transport. Compared to wild type hDAT (WT hDAT), mutation of histidine547 (H547A) displayed a 196% increase in DA uptake. Other substitutions of histidine547 showed that DA uptake was not altered in H547R but decreased by 99% …
Kaempferol-Phospholipid Complex: Formulation, And Evaluation Of Improved Solubility, In Vivo Bioavailability, And Antioxidant Potential Of Kaempferol, Darshan R. Telange, Arun T. Patil, Anil M. Pethe, Amol A. Tatode, Sridhar Anand, Vivek S. Dave
Kaempferol-Phospholipid Complex: Formulation, And Evaluation Of Improved Solubility, In Vivo Bioavailability, And Antioxidant Potential Of Kaempferol, Darshan R. Telange, Arun T. Patil, Anil M. Pethe, Amol A. Tatode, Sridhar Anand, Vivek S. Dave
Pharmacy Faculty/Staff Publications
The current work describes the formulation and evaluation of a phospholipid complex of kaempferol toenhance the latter’s aqueous solubility, in vitro dissolution rate, in vivo antioxidant and hepatoprotectiveactivities, and oral bioavailability. The kaempferol-phospholipid complex was synthesized using a freeze-drying method with the formulation being optimized using a full factorial design (32) approach. The resultsinclude the validation of the mathematical model in order to ascertain the role of specific formulation andprocess variables that contribute favorably to the formulation’s development. The final product wascharacterized and confirmed by Differential Scanning Calorimetry (DSC), Fourier Transform InfraredSpectroscopy (FTIR), Proton Nuclear Magnetic Resonance Spectroscopy (1H-NMR), and …
Formulation And Characterization Of An Apigenin-Phospholipid Phytosome (Aplc) For Improved Solubility, In Vivo Bioavailability, And Antioxidant Potential, Darshan R. Telange, Arun T. Patin, Anil M. Pethe, Harshal Fegade, Sridhar Anand, Vivek S. Dave
Formulation And Characterization Of An Apigenin-Phospholipid Phytosome (Aplc) For Improved Solubility, In Vivo Bioavailability, And Antioxidant Potential, Darshan R. Telange, Arun T. Patin, Anil M. Pethe, Harshal Fegade, Sridhar Anand, Vivek S. Dave
Pharmacy Faculty/Staff Publications
The apigenin-phospholipid phytosome (APLC) was developed to improve the aqueous solubility, dissolution, in vivo bioavailability, and antioxidant activity of apigenin. The APLC synthesis was guided by a full factorial design strategy, incorporating specific formulation and process variables to deliver an optimized product. The design-optimized formulation was assayed for aqueous solubility, in vitro dissolution, pharmacokinetics, and antioxidant activity. The pharmacological evaluation was carried out by assessing its effects on carbon tetrachloride-induced elevation of liver function marker enzymes in a rat model. The antioxidant activity was assessed by studying its effects on the liver antioxidant marker enzymes. The developed model was validated …
Pharmacotherapeutic Considerations For Individuals With Down Syndrome, Erik Hefti
Pharmacotherapeutic Considerations For Individuals With Down Syndrome, Erik Hefti
Harrisburg University Faculty Works
Down syndrome (DS; trisomy 21) is the most common survivable disorder due to aneuploidy. Individuals with DS may experience multiple comorbid health problems including congenital heart defects, endocrine abnormalities, skin and dental problems, seizure disorders, leukemia, dementia, and obesity. These associated conditions may necessitate pharmacotherapeutic management with various drugs. The complex pathobiology of DS may alter drug disposition and drug response in some individuals. For example, reports have documented increased rates of adverse drug reactions in patients with DS treated for leukemia and dementia. Intellectual disability resulting from DS may impact adherence to medication regimens. In this review, we highlight …
Assessment Of Iron Sucrose Use At A Community-Based Hospital, Ada Jalice, Mercedes Frias, Yarelys Garcia
Assessment Of Iron Sucrose Use At A Community-Based Hospital, Ada Jalice, Mercedes Frias, Yarelys Garcia
All Publications
No abstract provided.
Evaluation Of An Empiric Vancomycin Dosing Nomogram In Achieving Goal Steady-State Trough Concentrations In Obese Adults Weighing At Least 100 Kilograms, S. W. Johnson, R. D. Bowers, A. A. Cooper, C. L. Wente, D. Wilson
Evaluation Of An Empiric Vancomycin Dosing Nomogram In Achieving Goal Steady-State Trough Concentrations In Obese Adults Weighing At Least 100 Kilograms, S. W. Johnson, R. D. Bowers, A. A. Cooper, C. L. Wente, D. Wilson
Pharmacy Practice
No abstract provided.
Sneaky Salt Contributes To High Blood Pressure, Rodney Richmond
Sneaky Salt Contributes To High Blood Pressure, Rodney Richmond
College of Pharmacy Faculty Research and Publications
No abstract provided.
Bridging The Gap: Characterization Of A Dual Pharmacist Role In Drug Information And Investigational Drug Services, Lauren Karel, Pharmd, Bcps, Rania Sadaka, Pharmd, Cindy Wordell, Pharmd, Bcps, Fashp
Bridging The Gap: Characterization Of A Dual Pharmacist Role In Drug Information And Investigational Drug Services, Lauren Karel, Pharmd, Bcps, Rania Sadaka, Pharmd, Cindy Wordell, Pharmd, Bcps, Fashp
Pharmacy Presentations, Posters, and Grand Rounds
Background
• Thomas Jefferson University Hospital (TJUH) is a tertiary academic medical center with 951 licensed beds
• TJUH offers a wide variety of clinical services, as well as multiple residency programs including a PGY2 specialty residency in Drug Information
• The Investigational Drug Service (IDS) at TJUH is responsible for the procurement, storage, dispensing and maintenance of records for inpatient and outpatient clinical trials
o IDS pharmacy staff ensure study drug medication safety, patient safety, and local, state, national, and federal regulatory compliance for all investigational drug research
Formulating A Pharmacy Collection Without A Prescription, Kristin Laughtin-Dunker, Linda Galloway
Formulating A Pharmacy Collection Without A Prescription, Kristin Laughtin-Dunker, Linda Galloway
Library Articles and Research
Librarians without a background in the health sciences were tasked with building a collection to support a new pharmacy school at a traditionally liberal arts institution. Despite little subject expertise, the team assessed current holdings, conducted a review of recommended resources, and collaborated with faculty to prioritize acquisitions to support the developing program as funds became available. The hire of a health sciences librarian provided new opportunities for assessment and for continued collecting. Altogether, this process allowed for the creation of recommended best practices that can be adopted by any librarian procuring resources to support new health science programs.
Medication Adherence In Patients With Myotonic Dystrophy And Facioscapulohumeral Muscular Dystrophy, Bryan Fitzgerald, Kelly Conn, Joanne Smith, Andrew Walker, Amy L. Parkhill, James E. Hilbert, Elizabeth A. Luebbe, Richard T. Moxley Iii
Medication Adherence In Patients With Myotonic Dystrophy And Facioscapulohumeral Muscular Dystrophy, Bryan Fitzgerald, Kelly Conn, Joanne Smith, Andrew Walker, Amy L. Parkhill, James E. Hilbert, Elizabeth A. Luebbe, Richard T. Moxley Iii
Doctoral External Publications
Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are the two most common adult muscular dystrophies and have progressive and often disabling manifestations. Higher levels of medication adherence lead to better health outcomes, especially important to patients with DM and FSHD because of their multisystem manifestations and complexity of care. However, medication adherence has not previously been studied in a large cohort of DM type 1 (DM1), DM type 2 (DM2), and FSHD patients. The purpose of our study was to survey medication adherence and disease manifestations in patients enrolled in the NIH-supported National DM and FSHD Registry. The study …
Evaluation Of Over The Counter Medication Knowledge And Literacy In Middle School And High School Students, Tessa Kelly, Kelly M. Conn, Allison Bosworth, Matthew Zak
Evaluation Of Over The Counter Medication Knowledge And Literacy In Middle School And High School Students, Tessa Kelly, Kelly M. Conn, Allison Bosworth, Matthew Zak
Doctoral External Publications
Over the counter (OTC) medications are commonly utilized by the public, including adolescents, to self-treat many conditions. Unfortunately, these products can be dangerous if not used safely and appropriately. Adolescents between 13 and 19 years old composed 7.32 percent of the human exposure cases reported to U.S. poison control centers in 2014. Among these cases, there were 53 fatalities involving pharmaceuticals. This is an age range where medication use becomes more independent and the education they receive throughout the school curriculum is unknown. This study was designed to evaluate OTC medication knowledge and literacy among middle and high school students.
Volumetry Of Low-Contrast Liver Lesions With Ct: Investigation Of Estimation Uncertainties In A Phantom Study, Qin Li, Yongguang Liang, Qiao Huang, Min Zong, Benjamin Berman, Marios A. Gavrielides, Lawrence H. Schwartz, Binsheng Zhao, Nicholas Petrick
Volumetry Of Low-Contrast Liver Lesions With Ct: Investigation Of Estimation Uncertainties In A Phantom Study, Qin Li, Yongguang Liang, Qiao Huang, Min Zong, Benjamin Berman, Marios A. Gavrielides, Lawrence H. Schwartz, Binsheng Zhao, Nicholas Petrick
Food and Drug Administration Papers
Purpose: To evaluate the performance of lesion volumetry in hepatic CT as a function of various imaging acquisition parameters.
Methods: An anthropomorphic abdominal phantom with removable liver inserts was designed for this study. Two liver inserts, each containing 19 synthetic lesions with varying diameter (6–40 mm), shape, contrast (10–65 HU), and both homogenous and mixed-density were designed to have background and lesion CT values corresponding to arterial and portal-venous phase imaging, respectively. The two phantoms were scanned using two commercial CT scanners (GE 750 HD and Siemens Biograph mCT) across a set of imaging protocols (four slice thicknesses, …
Determination Of Secondary Encounter Rates For Urinary Tract Infections In Patients Treated With Cephalexin, Aubrey Goertel Pharmd, Jarrod W. Kile Rphd
Determination Of Secondary Encounter Rates For Urinary Tract Infections In Patients Treated With Cephalexin, Aubrey Goertel Pharmd, Jarrod W. Kile Rphd
Department of Pharmacy
No abstract provided.
Time To First Antibiotic Administration In Adult Oncology Patients With Fever Who Present To The Emergency Department And Infusion Centers, Breana Goscicki Pharmd, Janine Barnaby Rph, Bcop
Time To First Antibiotic Administration In Adult Oncology Patients With Fever Who Present To The Emergency Department And Infusion Centers, Breana Goscicki Pharmd, Janine Barnaby Rph, Bcop
Department of Pharmacy
No abstract provided.
Fructose Alters Cell Survival And Gene Expression In Microglia And Neuronal Cells Lines, Drew P. Seidel, Susan Denapoli, Thomas S. Maciulewicz, Melinda E. Lull
Fructose Alters Cell Survival And Gene Expression In Microglia And Neuronal Cells Lines, Drew P. Seidel, Susan Denapoli, Thomas S. Maciulewicz, Melinda E. Lull
Pharmacy Faculty/Staff Publications
Purpose: Microglia are macrophages that are found primarily in the CNS and play a crucial role in maintaining a healthy brain by engulfing invading microorganisms, releasing inflammatory mediators, and pruning dead cells. Microglia can become activated in response to certain stimuli which causes them to transition into a pro-inflammatory state, and can sometimes become chronically activated which can result in neuronal damage. Studies have shown a causal relationship between this activation and sugars such as fructose and glucose. We sought to understand the role of sugars in microglial activation and the subsequent effects on neuron health.
Methods: Rat microglia (HAPI) …
Carriers For The Tunable Release Of Therapeutics: Etymological Classification And Examples, Vuk Uskoković, Shreya Ghosh
Carriers For The Tunable Release Of Therapeutics: Etymological Classification And Examples, Vuk Uskoković, Shreya Ghosh
Pharmacy Faculty Articles and Research
Introduction—Physiological processes at the molecular level take place at precise spatiotemporal scales, which vary from tissue to tissue and from one patient to another, implying the need for the carriers that enable tunable release of therapeutics.
Areas Covered—Classification of all drug release to intrinsic and extrinsic is proposed, followed by the etymological clarification of the term “tunable” and its distinction from the term “tailorable”. Tunability is defined as analogous to tuning a guitar string or a radio receiver to the right frequency using a single knob. It implies changing a structural parameter along a continuous quantitative scale and …
Bis-Quaternary Ammonium Salts As Pain Modulating Agents, Joseph R. Holtman, Peter A. Crooks, Linda Phyliss Dwoskin, J. Michael Mcintosh
Bis-Quaternary Ammonium Salts As Pain Modulating Agents, Joseph R. Holtman, Peter A. Crooks, Linda Phyliss Dwoskin, J. Michael Mcintosh
Pharmaceutical Sciences Faculty Patents
Provided are methods for using his-quaternary ammonium compounds to treat inflammatory pain, neuropathic pain and nociceptive pain.
Design, Synthesis, And Evaluation Of Dasatinib-Amino Acid And Dasatinib-Fatty Acid Conjugates As Protein Tyrosine Kinase Inhibitors, Rakesh Tiwari, Alex Brown, Neda Sadeghiani, Amir Nasrolahi Shirazi, Jared Bolton, Amanda Tse, Gennady M. Verkhivker, Keykavous Parang, Gongqin Sun
Design, Synthesis, And Evaluation Of Dasatinib-Amino Acid And Dasatinib-Fatty Acid Conjugates As Protein Tyrosine Kinase Inhibitors, Rakesh Tiwari, Alex Brown, Neda Sadeghiani, Amir Nasrolahi Shirazi, Jared Bolton, Amanda Tse, Gennady M. Verkhivker, Keykavous Parang, Gongqin Sun
Pharmacy Faculty Articles and Research
Derivatives of dasatinib were synthesized via esterification with 25 carboxylic acids including amino acids and fatty acids by extending the inhibitor to interact with more diverse sites and to improve specificity. Dasatinib-L-arginine derivative (Das-R, 7) was the most potent of the inhibitors tested with IC50 values of 4.4 nM, <0.25 nM, and <0.45 nM against Csk, Src, and Abl kinases, respectively. The highest selectivity ratio obtained in our study, 91.4 Csk/Src belonged to compound 18 (Das-C10) with an IC50 of 3.2 μM for Csk compared to 35 nM for Src. Furthermore, many compounds displayed increased selectivity toward Src, as compared with Abl. Compounds 15 (Das-E) and 13 (Das-C) demonstrated the largest gains (10.2 and 10.3 Abl/Src IC50 ratios). Das-R (IC50 = 2.06 μM) was significantly more potent than Das (IC50 = 26.3 μM) against Panc-1 cells while they both showed an IC50 < 51.2 pM against BV-173 and K562 cells. Molecular modeling and binding free energy simulations revealed a good agreement with the experimental results and rationalized differences in selectivity of the studied compounds. Integration of experimental and computational approaches in the design and biochemical screening of dasatinib derivatives facilitated rational engineering and diversification of dasatinib scaffold, providing useful insights into mechanisms of kinase selectivity.
Moseying Along At The Fda, Rodney Richmond
Moseying Along At The Fda, Rodney Richmond
College of Pharmacy Faculty Research and Publications
No abstract provided.
Causal Inference For Biomedical Research Php/Sta 592, Joanna Burkhardt
Causal Inference For Biomedical Research Php/Sta 592, Joanna Burkhardt
Library Impact Statements
No abstract provided.
Proteasome Inhibitors, Kyung Bo Kim, Venod Kasam, Wooin Lee, Dong-Eun Kim, Zachary Miller, Chang-Guo Zhan, Do-Min Lee
Proteasome Inhibitors, Kyung Bo Kim, Venod Kasam, Wooin Lee, Dong-Eun Kim, Zachary Miller, Chang-Guo Zhan, Do-Min Lee
Pharmaceutical Sciences Faculty Patents
To see this patent's abstract, please download it.